14.05.2013 Views

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

along with the augmentation <strong>in</strong> cardiac<br />

output and uter<strong>in</strong>e blood flow, makes it a<br />

good selection for the treatment <strong>of</strong><br />

gestational Hypertension.<br />

If the diastolic blood pressure exceeded<br />

110 mm Hg, Hydralaz<strong>in</strong>e (Apresol<strong>in</strong>e)<br />

can be adm<strong>in</strong>istered as follows. A test<br />

dose <strong>of</strong> 5 mg is <strong>in</strong>jected as a bolus<br />

<strong>in</strong>travenously and the blood pressure<br />

monitored every 5 m<strong>in</strong>utes. If the<br />

diastolic pressure is not lowered to about<br />

100 mm Hg <strong>in</strong> 20 m<strong>in</strong>utes, a 10 mg dose<br />

is similarly adm<strong>in</strong>istered, and its effects<br />

are monitored. This dose can be repeated<br />

until the diastolic blood pressure is<br />

lowered to about 100 mm Hg.<br />

Rauwolfia compounds (Reserp<strong>in</strong>e) –<br />

The rauwolfia compounds <strong>in</strong>terfere with<br />

chemical neurotransmission at the post<br />

ganglionic adrenergic nerve end<strong>in</strong>gs and<br />

results <strong>in</strong> decreased peripheral vascular<br />

resistance. The peripheral effect is a<br />

result <strong>of</strong> depletion <strong>of</strong> term<strong>in</strong>al post<br />

ganglionic catecholam<strong>in</strong>e stores and<br />

reduced catecholam<strong>in</strong>e uptake, lead<strong>in</strong>g<br />

to maximum catecholam<strong>in</strong>e depletion <strong>in</strong><br />

24 hours. A second, though less<br />

effective, hypotensive mechanism may<br />

be a direct action on the vasomotor<br />

center <strong>of</strong> the bra<strong>in</strong>, secondary to<br />

depletion <strong>of</strong> CNS catecholam<strong>in</strong>es.<br />

Because <strong>of</strong> the slow restoration rate <strong>of</strong><br />

tissue catecholam<strong>in</strong>es, the antihypertensive<br />

effect <strong>of</strong> Reserp<strong>in</strong>e may last<br />

several days after the f<strong>in</strong>al dose.<br />

Increased parasympathetic activity can<br />

result <strong>in</strong> bradycardia, nasal congestion,<br />

<strong>in</strong>creased salivation, cramps and<br />

diarrhea. Other maternal side effects are<br />

depression, <strong>in</strong>creased water and sodium<br />

retention, sedation and decreased plasma<br />

ren<strong>in</strong> levels. The major fetal com-<br />

58<br />

plication is neonatal respiratory difficulty<br />

secondary' to nasal conges tion.<br />

Despite the side effects and the<br />

anesthetic risks <strong>of</strong> catecholam<strong>in</strong>e depletion,<br />

Reserp<strong>in</strong>e is a good alternative antihypertensive<br />

agent for both long-term<br />

and acute management <strong>of</strong> gestational<br />

hypertension.<br />

Propranolol (Inderal) - Inderal is a beta<br />

adrenergic block<strong>in</strong>g agent which decreases<br />

the force and frequency <strong>of</strong><br />

myocardial contractions. This results <strong>in</strong><br />

reduction <strong>in</strong> cardiac output and an <strong>in</strong>itial<br />

elevation <strong>in</strong> peripheral vascular resistance,<br />

which decreases with cont<strong>in</strong>ued<br />

drug usage. Chronic adm<strong>in</strong>is-tration <strong>of</strong><br />

propranolol can cause a reduction <strong>in</strong><br />

plasma ren<strong>in</strong>, possibly due to its direct<br />

effect upon the kidneys. The result <strong>of</strong><br />

treatment is a decrease <strong>in</strong> systolic and<br />

diastolic pressure, without orthostatic<br />

hypotension. Reported maternal side<br />

effects have been nightmares and<br />

drows<strong>in</strong>ess. Use <strong>of</strong> propranolol <strong>in</strong> asthmatic<br />

patients my lead to aggravation <strong>of</strong><br />

bronchospasm.<br />

Beta blockade and the lower<strong>in</strong>g <strong>of</strong><br />

cardiac output, have no place <strong>in</strong> the<br />

management <strong>of</strong> hypertension dur<strong>in</strong>g pregnancy.<br />

Eclampsia - This is def<strong>in</strong>ed as disease <strong>in</strong><br />

which fits occur with pre eclampsia.<br />

Cl<strong>in</strong>ical features - In this condition both<br />

clonic and tonic convulsions occur, there<br />

is <strong>of</strong>ten severe hypertension present. The<br />

condition may occur dur<strong>in</strong>g antepartum,<br />

<strong>in</strong>trapartum or postpartum period. Most<br />

frequently the complication occurs <strong>in</strong> the<br />

last trimester and near term. Almost all<br />

cases <strong>of</strong> postpartum eclampsia occur<br />

with<strong>in</strong> 24 hours after delivery 24 hours<br />

is the usual limit given though some

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!